Filing Details

Accession Number:
0001447362-21-000070
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-07 18:15:49
Reporting Period:
2021-04-05
Accepted Time:
2021-04-07 18:15:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447362 Castle Biosciences Inc CSTL Pharmaceutical Preparations (2834) CA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1024008 S David Kabakoff C/O Castle Biosciences, Inc.
505 S. Friendswood Drive, Suite 401
Friendswood TX 77546
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-05 50,000 $71.79 593,577 No 4 S Indirect By L.P.
Common Stock Disposition 2021-04-05 20,000 $73.22 573,577 No 4 S Indirect By L.P.
Common Stock Disposition 2021-04-06 40,000 $73.99 533,577 No 4 S Indirect By L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By L.P.
No 4 S Indirect By L.P.
No 4 S Indirect By L.P.
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by Sofinnova HealthQuest Partners, L.P. on December 17, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $71.1820 to $72.1647, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Held by Sofinnova HealthQuest Partners, L.P., or HealthQuest Partners. HealthQuest Venture Management, L.L.C., or HealthQuest Management, is the general partner of HealthQuest Partners. David Kabakoff, Ph.D., the Reporting Person, is a partner of HealthQuest Management. Garheng Kong is the managing member of HealthQuest Management and has sole voting and investment power over the shares held by HealthQuest Partners. Each of HealthQuest Management, Mr. Kong and Dr. Kabakoff disclaims beneficial ownership over all shares held by HealthQuest Partners except to the extent of any pecuniary interest therein.
  4. This transaction was executed in multiple trades at prices ranging from $73.1857 to $73.2564, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $73.4821 to $74.1945, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.